IntegriChain Revenue & Funding (2024)

Kevin Leininger

CEO

Kevin co-founded IntegriChain in 2006 and has grown the company into a leading multi-national life sciences commercial data and analytics enterprise that helps patients start therapy faster and stay in therapy longer. As Chief Executive Officer, Kevin is responsible for corporate management and leadership, strategic planning, organizing and coordination of the executive management team. Prior to IntegriChain, he spent 20 years building and launching software and services companies in the financial services, petroleum and pharmaceutical industries, some leading to initial public offerings (IPOs). He has authored six books on Unix, the Internet and Java and has spoken at conferences and seminars around the world. Kevin is a member of the CEO Council for Growth of the Chamber of Commerce for Greater Philadelphia, focusing on the Cell and Gene Therapy Connected Health Initiative. He also serves as an Advisory Board Member of Ben Franklin Technology Partners of Southeastern Pennsylvania and as a Mentor with Dreamit Ventures. He is also a member of the Iowa State University Physics Advisory Council. Kevin earned a Bachelor of Science in physics from Iowa State University and a Master of Business Administration in international business and finance from the University of Chicago Booth School of Business.